RECRUITING

Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates the use of a wearable vest capable of non-invasively measuring lung fluid content in hospitalized patients with heart failure

Official Title

Remote Dielectric Sensing Technology Guided Diuresis in Hospitalized Patients With Acute Decompensated Heart Failure

Quick Facts

Study Start:2018-12-01

Study Completion:2025-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT03586336

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Patients hospitalized for acute decompensated heart failure requiring treatment with intravenous diuretics and/or IV vasoactive drugs * Patient has signed informed consent and has authorized use and disclosed health information * Patient is at least 18 years of age * Patient physically suitable for ReDS measurement * GFR\>25 * Initial ReDS Measurement \>35%	* Patient characteristics excluded from approved use of ReDS system: height less than 155cm or greater than 190cm, BMI \<22 or \>39, chest circumference \<80cm or \>115cm , or flail chest * Evidence of focal lung lesions on history, physical exam or chest x-ray, including history of pulmonary embolism, active pneumonia, or known lung nodule * Chronic renal failure (GFR\<25) * Prior cardiac surgery within 2 months of index admission * Patient has a ventricular assist device or has had a cardiac transplantation * Patients in cardiogenic shock at admission requiring inotropic support * Congenital heart malformations or intra-thoracic mass that would affect right-lung anatomy (e.g dextrocardia, lung carcinoma, or pacemaker box in the right chest)

Inclusion Criteria

Exclusion Criteria

* Patients hospitalized for acute decompensated heart failure requiring treatment with intravenous diuretics and/or IV vasoactive drugs
* Patient has signed informed consent and has authorized use and disclosed health information
* Patient is at least 18 years of age
* Patient physically suitable for ReDS measurement
* GFR\>25
* Initial ReDS Measurement \>35%

* Patient characteristics excluded from approved use of ReDS system: height less than 155cm or greater than 190cm, BMI \<22 or \>39, chest circumference \<80cm or \>115cm , or flail chest
* Evidence of focal lung lesions on history, physical exam or chest x-ray, including history of pulmonary embolism, active pneumonia, or known lung nodule
* Chronic renal failure (GFR\<25)
* Prior cardiac surgery within 2 months of index admission
* Patient has a ventricular assist device or has had a cardiac transplantation
* Patients in cardiogenic shock at admission requiring inotropic support
* Congenital heart malformations or intra-thoracic mass that would affect right-lung anatomy (e.g dextrocardia, lung carcinoma, or pacemaker box in the right chest)

Contacts and Locations

Study Contact

Cynthia Partida-Higuera

CONTACT

415-514-1125

Cynthia.Partida-Higuera@ucsf.edu

Liviu Klein, MD, MS

CONTACT

415-476-2143

liviu.klein@ucsf.edu

Principal Investigator

Liviu Klein, MD, MS

PRINCIPAL_INVESTIGATOR

Director, Mechanical Circulatory Support and Heart Failure Device Program

Study Locations (Sites)

University of California, San Francisco

San Francisco, California, 94143

United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

Liviu Klein, MD, MS, PRINCIPAL_INVESTIGATOR, Director, Mechanical Circulatory Support and Heart Failure Device Program

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-12-01

Study Completion Date2025-12-31

Study Record Updates

Study Start Date2018-12-01

Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

Heart Failure; With Decompensation